Adalimumab (Humira®)

Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2013
Cargando información sobre las referencias

RECORD STATUS:

This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.

CITATION:

All Wales Medicines Strategy Group (AWMSG). Adalimumab (Humira®) Penarth: All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG). AWMSG Secretariat Assessment Report Advice No.1513. 2013
Epistemonikos ID: 877082357baa6a62f97bada46d365b86baff506b
First added on: Feb 06, 2015